Background And Objectives: A clinical practice guideline (CPG) was created to standardize evaluation and treatment for patients with suspected anti-methyl-d-aspartate receptor (NMDAR) autoimmune encephalitis (AE), the most common AE in children. The objective of this study was to evaluate the CPG effect on time to diagnosis, treatment, and hospital length of stay (LOS).
Methods: Patients with an inpatient consult to pediatric rheumatology for AE during a 4-year period (period 2) after CPG implementation were identified.
Background: Vaccine-induced phantosmia is a rare adverse effect of vaccination and has not been previously reported related to the Johnson & Johnson (J&J) COVID-19 vaccine.
Case Presentation: Three weeks after receiving the J&J COVID-19 vaccine, a 39-year-old veteran started smelling a burning odor in the absence of an identifiable source. At presentation to the clinic, his general and neurological examinations, brain magnetic resonance imaging, and electroencephalogram were all unremarkable.
Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke which affects the retina. Intravenous thrombolysis is emerging as a compelling therapeutic approach. However, it is not known which patients may benefit from this therapy because there are no imaging modalities that adequately distinguish viable retina from irreversibly infarcted retina.
View Article and Find Full Text PDF